Goodrx Holdings Inc
NASDAQ:GDRX
Intrinsic Value
GoodRx Holdings, Inc. operates a consumer-focused digital healthcare platform. [ Read More ]
The intrinsic value of one GDRX stock under the Base Case scenario is 8.76 USD. Compared to the current market price of 6.69 USD, Goodrx Holdings Inc is Undervalued by 24%.
Valuation Backtest
Goodrx Holdings Inc
Run backtest to discover the historical profit from buying and selling GDRX stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Goodrx Holdings Inc
Current Assets | 872.8m |
Cash & Short-Term Investments | 672.3m |
Receivables | 147.1m |
Other Current Assets | 53.3m |
Non-Current Assets | 716m |
PP&E | 45.9m |
Intangibles | 567.1m |
Other Non-Current Assets | 103m |
Current Liabilities | 122.6m |
Accounts Payable | 36.3m |
Accrued Liabilities | 70.4m |
Other Current Liabilities | 15.9m |
Non-Current Liabilities | 704.3m |
Long-Term Debt | 647.7m |
Other Non-Current Liabilities | 56.6m |
Earnings Waterfall
Goodrx Holdings Inc
Revenue
|
750.3m
USD
|
Cost of Revenue
|
-66.9m
USD
|
Gross Profit
|
683.3m
USD
|
Operating Expenses
|
-708.6m
USD
|
Operating Income
|
-25.2m
USD
|
Other Expenses
|
16.4m
USD
|
Net Income
|
-8.9m
USD
|
Free Cash Flow Analysis
Goodrx Holdings Inc
What is Free Cash Flow?
GDRX Profitability Score
Profitability Due Diligence
Goodrx Holdings Inc's profitability score is 41/100. The higher the profitability score, the more profitable the company is.
Score
Goodrx Holdings Inc's profitability score is 41/100. The higher the profitability score, the more profitable the company is.
GDRX Solvency Score
Solvency Due Diligence
Goodrx Holdings Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Score
Goodrx Holdings Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GDRX Price Targets Summary
Goodrx Holdings Inc
According to Wall Street analysts, the average 1-year price target for GDRX is 8.94 USD with a low forecast of 5.05 USD and a high forecast of 14.7 USD.
Ownership
GDRX Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
GDRX Price
Goodrx Holdings Inc
Average Annual Return | -41.7% |
Standard Deviation of Annual Returns | 37.99% |
Max Drawdown | -93% |
Market Capitalization | 2.6B USD |
Shares Outstanding | 403 248 000 |
Percentage of Shares Shorted | 11.12% |
GDRX News
Last Important Events
Goodrx Holdings Inc
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Goodrx Holdings Inc
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
GoodRx Holdings, Inc. operates a consumer-focused digital healthcare platform. The company is headquartered in Santa Monica, California and currently employs 756 full-time employees. The company went IPO on 2020-09-23. The firm provides GoodRx platform, which aggregates and analyzes pricing data from a number of different sources. Its platform also provides access to medication savings programs, medical provider consultations and lab tests through its telehealth offerings, GoodRx Care and the GoodRx Telehealth Marketplace, and other healthcare related content. Its prescription offering provides price comparisons and negotiated prices on prescriptions. Its subscription offerings provide consumers and their families with access to lower prescription prices on select medications in select pharmacies for a monthly or annual subscription fee. Its pharmaceutical manufacturer solutions offering provides advertising and integrated consumer affordability solutions to pharmaceutical manufacturers.
Contact
IPO
Employees
Officers
The intrinsic value of one GDRX stock under the Base Case scenario is 8.76 USD.
Compared to the current market price of 6.69 USD, Goodrx Holdings Inc is Undervalued by 24%.